Communication

News

VIEWaves – new member

24 May 2022
New member

VIEWavesTo help surgeons, we have developed innovative, stable and robust fluorescent molecules. They will be grafted onto antibodies that will specifically recognize tumor cells. These new molecules will emit intense light in the near-infrared range that will precisely identify the contours of the tumor. This light will guide surgeons in removing cancerous tumors. To know more